May 16, 2017 — Here is a list of the late-breaking clinical trials presented at the Heart Rhythm Society (HRS) 2017 annual meeting May 10-13, in Chicago. The data presented is for the latest in electrophysiology (EP) clinical research, techniques and technologies. These trials were featured at Heart Rhythm 2017 and will be published in the July issue of the Heart Rhythm Journal.
Late-breaking Studies Presented at HRS 2017:
• A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation: The AEIOU (Apixaban Evaluation Of Interrupted Or Uninterrupted Anticoagulation For Ablation Of Atrial Fibrillation) Trial
• SPECT-guided Left Ventricular Lead Placement For Improved CRT Efficacy: A Randomized Controlled Trial
• Ranolazine in High-Risk ICD Patients (RAID) Trial
• The Nanostim Leadless Pacemaker: Battery Failures and Worldwide Chronic Device Retrieval
Other Key Presentations:
VIDEO: EP Lead Extraction Strategies, interview with Bruce Wilkoff, M.D.
VIDEO: Current State of Leadless Pacemaker Technology, interview with Vivek Reddy, M.D.
For more information: www.hrssessions.org